1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
about
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsThe Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated SymptomatologyEpidemiology of Uterine Myomas: A ReviewRecent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and managementParicalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroidsDietary components and uterine leiomyomas: a review of published data.1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.Vitamin D and assisted reproduction technologies: current concepts.Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata.Matrix production and remodeling as therapeutic targets for uterine leiomyomaRacial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Can vitamin D reduce the risk of uterine fibroids?Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapyEpidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Role of vitamin D in uterine fibroid biologyA Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment.Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid CellsVitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.Is the observed association between dairy intake and fibroids in African Americans explained by genetic ancestry?Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation.Vitamin d and the risk of uterine fibroids.Uterine fibroids: clinical manifestations and contemporary management.Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence.Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms.Role of Transforming Growth Factor β in Uterine Fibroid Biology.Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.Successes and failures of uterine leiomyoma drug discovery.25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma.Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts
P2860
Q24567733-5E5A3851-BDCB-428E-85C7-C02013FB2BDAQ26746157-8F51F39D-75E0-4799-A49A-A33F760AB966Q26764887-B410C150-0C1C-4B3C-819D-535F0F72BCD9Q26799918-D2516AD7-0900-4A03-9E6D-F19ED0A7308BQ30371213-ACE6CFB4-2324-4DD8-B32F-D3CBCC7DEBB1Q30920085-2B8AFE8C-1947-4FEF-89F5-90BAF7D0F7C3Q33826120-19C0E77F-947B-46FB-93C3-6BCE8BA7E2AFQ33848219-4042D3D3-ACEE-4306-ACE3-02D7492ABE79Q33992469-D419D186-6E67-4CE7-831B-C42DE8AA5743Q34195881-B51FCCD3-7B68-46F1-BF6F-1F1036467816Q34223004-BC39D822-1AB8-4AAE-8101-75ED23EDB266Q34403426-8E25375A-ECBB-40E7-83D6-08F261149FD0Q34437666-0DC72682-42D6-47C8-9EB3-02541F6D4845Q35441965-FBF32956-C03C-47A8-B60B-E1D77A0CBBB1Q35737921-B71293F8-8196-4E8B-BB82-B49076BA959EQ35855640-962D3E80-CDE1-41E2-BEDE-65F44FD9C8F4Q35944399-5FB62E0F-6EE5-4465-BFF1-71F37044B036Q36030956-48627A7E-F24A-4B56-B8F2-FBF7B3557F95Q36291778-45933B12-7C49-4656-A711-A54EF4C3EF96Q36935561-F87D4847-35B8-4F87-B7A5-5549859A0EBFQ37109082-A1E5B64F-93D4-4E9F-B6E7-38609995C25BQ37380101-4C562418-B448-4329-8088-A7EB4753181DQ37552132-C8D3FCA9-5967-42C2-9198-67DED0B3F0D0Q37671721-A59259D2-6CAC-4C9A-A549-86335EF8BD4DQ38211241-12015305-C66C-436A-BDC9-BC4B63770EE5Q38610901-7480BA39-5D38-41A9-8FA2-E8B84FBFE3C6Q38613463-D7040323-0CA1-4DEE-AD60-1B95EC782145Q41660259-AFD6092D-3934-44AE-920B-28A0A2EDD8F2Q47096314-2E9C9ED7-EAB0-4F8B-884A-B0A53F5AAE3DQ47217486-3E6311CA-AB23-4A0C-A566-DC6761F5E5B0Q47562528-01949E9A-A5D7-4694-B8B4-44AE8A7265E4Q47877933-C0CB9B94-586F-4672-A8AF-82E26646FC69Q57176044-FB61AB03-1D59-45B6-9150-88F44A5C325E
P2860
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@ast
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@en
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@nl
type
label
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@ast
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@en
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@nl
prefLabel
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@ast
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@en
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@nl
P2093
P2860
P3181
P1476
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model
@en
P2093
Ayman Al-Hendy
Chakradhari Sharan
Sunil K Halder
P2860
P3181
P356
10.1095/BIOLREPROD.111.098145
P407
P577
2012-04-01T00:00:00Z